about
Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypesInteraction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.The expression of vasoactive intestinal peptide receptor 1 is negatively modulated by microRNA 525-5p.Single nucleotide polymorphisms in the 3'UTR of VPAC-1 cooperate in modulating gene expression and impact differently on the interaction with miR525-5p.Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation.The Ankylosing Spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients.The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia.Divergent effect of cobalt and beryllium salts on the fate of peripheral blood monocytes and T lymphocytes.HLA Class I or Class II and Disease Association: Catch the Difference If You Can.Gender-dependent association of type 2 diabetes with the vasoactive intestinal peptide receptor 1.AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian populationIdentification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA–B27 extended haplotypes in sardiniaDistribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathiesCD8+ T-cell mediated self-reactivity in HLA-B27 context as a consequence of dual peptide conformationA functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B *2705 in SardiniaAn allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genesUnusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation
P50
Q27651301-1AF93D73-9F1C-454B-8B8A-052BE2C916D4Q29417082-D36A4ABC-5491-4C0E-8642-39D99F8276ABQ33656489-8D07552C-6BC6-49BF-90C5-828467999E3FQ33656489-9ED48FE8-3121-4638-8F2D-139C53CF3ACAQ35414146-96FBFAA6-0744-4EC4-973D-5FD7A6EBB086Q38840532-F106416A-7A40-4F8F-95CC-D781B5E9811CQ39715318-45ED4C59-777C-44D3-AB27-2A84100D1DC9Q40101435-524198B7-AD96-49EF-BA14-8B3DF0179F7FQ41201765-1FF020BE-DE78-4541-B737-7FEB8EC65D1EQ42848229-DC0B8A51-23D7-420C-B4F2-1AED130DDDCDQ47111038-989DBD43-1012-407B-9830-723A7ECA24B1Q51375974-7C088346-4103-4DC7-865F-3FFAC401C496Q58699197-129015B9-D15D-4DBD-B567-4D6F8EDC9DEFQ58852357-29E0D77F-EE99-405D-9B0C-1745B7194B74Q61649571-1D4A5D92-52B2-4E03-B3AE-C8ED7CF28F20Q62593802-EA93C5DA-6DBF-4A2F-BFDF-52140A1556A4Q62593836-9409E850-3EF7-4BE0-B377-F0371859A77AQ89508648-0E03C5C8-A912-4642-8143-43BD1A1232CBQ92853193-616846FF-8038-47A7-B0D4-6611135BE02A
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Fabiana Paladini
@ast
Fabiana Paladini
@en
Fabiana Paladini
@es
Fabiana Paladini
@nl
type
label
Fabiana Paladini
@ast
Fabiana Paladini
@en
Fabiana Paladini
@es
Fabiana Paladini
@nl
prefLabel
Fabiana Paladini
@ast
Fabiana Paladini
@en
Fabiana Paladini
@es
Fabiana Paladini
@nl
P106
P1153
8971159400
P31
P496
0000-0003-1040-452X